-
EP3813848
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3813848
| EP3813848 - PERSONALIZED CANCER VACCINE EPITOPE SELECTION [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 03.04.2021 Database last updated on 26.07.2024 | |
| Former | The international publication has been made Status updated on 03.01.2020 | Most recent event Tooltip | 14.06.2024 | Change - applicant | published on 17.07.2024 [2024/29] | Applicant(s) | For all designated states ModernaTX, Inc. 325 Binney Street Cambridge, MA 02142 / US | [2024/29] |
| Former [2021/18] | For all designated states ModernaTX, Inc. 200 Technology Square Cambridge, MA 02139 / US | Inventor(s) | 01 /
ZHONG, Shan 200 Technology Square Cambridge, MA 02139 / US | 02 /
BRETON, Benjamin 200 Technology Square Cambridge, MA 02141 / US | 03 /
MCFADYEN, Iain 11 Amherst Street Arlington, MA 02474 / US | 04 /
HOPSON, Kristen 331 Appleton Street Arlington, MA 02476 / US | 05 /
LUCZKOW, Vincent 200 Technology Square Cambridge, MA 02141 / US | 06 /
GARNAAS, Maija 112 Highland Avenue, Unit B Somerville, MA 02143 / US | [2021/18] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2021/18] | Application number, filing date | 19826546.4 | 27.06.2019 | [2021/18] | WO2019US39521 | Priority number, date | US201862690441P | 27.06.2018 Original published format: US 201862690441 P | US201862757045P | 07.11.2018 Original published format: US 201862757045 P | US201962814200P | 05.03.2019 Original published format: US 201962814200 P | US201962855311P | 31.05.2019 Original published format: US 201962855311 P | [2021/18] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020006242 | Date: | 02.01.2020 | Language: | EN | [2020/01] | Type: | A1 Application with search report | No.: | EP3813848 | Date: | 05.05.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 02.01.2020 takes the place of the publication of the European patent application. | [2021/18] | Search report(s) | International search report - published on: | AU | 02.01.2020 | (Supplementary) European search report - dispatched on: | EP | 22.06.2022 | Classification | IPC: | A61K31/7105, A61K31/711, A61K31/7115, A61K39/00, C12Q1/6886, G01N33/574 | [2021/18] | CPC: |
G01N33/57484 (EP,KR);
A61P35/00 (EP,AU,KR,US);
A61K39/0011 (EP,AU,KR,US);
A61K31/7105 (EP,KR);
A61K31/711 (EP,KR);
A61K31/7115 (EP,KR);
A61K48/0058 (AU);
A61K48/0066 (AU);
A61P37/04 (US);
G01N33/5011 (US);
G01N33/574 (KR);
G16B20/20 (EP,KR,US);
G16B20/30 (US);
G16B30/00 (AU,US);
G16B30/10 (EP,KR);
G16B40/00 (US);
A61K2039/53 (EP,AU,KR,US);
A61K2039/54 (US);
A61K2039/545 (US);
A61K2039/57 (US);
A61K2039/585 (KR);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/18] | Extension states | BA | 13.01.2021 | ME | 13.01.2021 | Validation states | KH | 13.01.2021 | MA | 13.01.2021 | MD | 13.01.2021 | TN | 13.01.2021 | Title | German: | EPITOPAUSWAHL FÜR PERSONALISIERTES KREBSVAKZIN | [2021/18] | English: | PERSONALIZED CANCER VACCINE EPITOPE SELECTION | [2021/18] | French: | SÉLECTION PERSONNALISÉE D'ÉPITOPES DE VACCINS CONTRE LE CANCER | [2021/18] | Entry into regional phase | 13.01.2021 | National basic fee paid | 13.01.2021 | Search fee paid | 13.01.2021 | Designation fee(s) paid | 13.01.2021 | Examination fee paid | Examination procedure | 13.01.2021 | Examination requested [2021/18] | 14.02.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time | 24.04.2023 | Amendment by applicant (claims and/or description) | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 24.04.2023 | Request for further processing filed | 24.04.2023 | Full payment received (date of receipt of payment) Request granted | 02.05.2023 | Decision despatched | Fees paid | Renewal fee | 14.06.2021 | Renewal fee patent year 03 | 13.05.2022 | Renewal fee patent year 04 | 31.03.2023 | Renewal fee patent year 05 | 17.05.2024 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2017020026 (MODERNATX INC [US]) [X] 1-17 * page 1, line 31 - page 12, line 33 * * page 15, line 13 - line 33 * * page 17, line 21 - page 22, line 33 * * page 66, line 3 - page 67, line 22 * * page 70, line 11 - line 21; example -; claim - *; | [X]WO2017070618 (MODERNATX INC [US]) [X] 1-17 * page 1, line 31 - page 16, line 26 * * page 23, line 9 - page 27, line 8 * * page 32, line 1 - page 37, line 28 * * page 71, line 5 - page 72, line 21; example -; claim - *; | [XP]WO2018144082 (MODERNATX INC [US]) [XP] 1-17* page 2, line 6 - page 27, line 19; claim - * | International search | [XY]WO2012159754 (BIONTECH AG [DE], et al) [X] 1-45, 47-91 * (D4 see: abstract; pages 2-4, 7, 9, 11, 16-17, 21-22, 25-26, 44-46, 51, 62, 77-79, Examples, Figures 6 and 8 and claims). (as above) * [Y] 1-45, 47-91; | [XY]WO2014168874 (BROAD INST INC [US], et al) [X] 1-45 47-91 * (D5: see abstract, pages 2-4, 7, 16, 31-34, 53, claims) (as above) * [Y] 1-45, 47-91; | [XY]WO2017020026 (MODERNATX INC [US]) [X] 1-45, 47-91 * (D1: see abstract, summary of the invention page 12, page 15-page 18, pages 20-22, pages 65-67, page 70, pages 127-129, claims). (as above) * [Y] 1-45, 47-91; | [XY]WO2017070618 (MODERNATX INC [US]) [X] 1-45, 47-91 * (D2: see abstract, pages 4-5, page 13-14, page 24, page 26-27, page 36, page 71-72, pages 87, and claims). (as above) * [Y] 1-45, 47-91; | [XP]WO2018144082 (MODERNATX INC [US]) [XP] 1-45, 47-91* (D8: see abstract, summary of the invention pages 2-26, claims) *; | [XY] - SAHIN, U. et al., "Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer", Nature, (20170713), vol. 547, no. 7662, doi:10.1038/nature23003, pages 222 - 226, XP002780019 [X] 1-45, 47-91 * . (D3: see abstract, page 222 both columns, page 223 left column, page 225 right column, page 227 both columns, and Extended Data Table 1). (as above) * [Y] 1-45, 47-91 DOI: http://dx.doi.org/10.1038/nature23003 | [Y] - ZHANG, X. et al., "Personalized cancer vaccines: Targeting the cancer mutanome", Vaccine, (20170215), vol. 35, no. 7, doi:10.1016/j.vaccine.2016.05.073, pages 1094 - 1100, XP029904248 [Y] 1-45, 47-91 * . (D6: see whole document, in particular Figure 2). * DOI: http://dx.doi.org/10.1016/j.vaccine.2016.05.073 | [Y] - HARTMAIER, R.J. et al., "Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies", Genome Med, (20170224), vol. 9, no. 16, pages 1 - 9, XP055630548 [Y] 1-45, 47-91 * . (D7: see abstract and background) * DOI: http://dx.doi.org/10.1186/s13073-017-0408-2 |